{
    "Trade/Device Name(s)": [
        "Liquid Stable (LS) 2-Part Homocysteine Reagent"
    ],
    "Submitter Information": "Catch Incorporated",
    "510(k) Number": "K062808",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011689"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LPS"
    ],
    "Summary Letter Date": "September 29, 2006",
    "Summary Letter Received Date": "October 3, 2006",
    "Submission Date": "September 15, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1377"
    ],
    "Regulation Name(s)": [
        "Urinary homocystine (non-quantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Homocysteine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Standard clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay"
    ],
    "Methodologies": [
        "Clinical enzymatic chemistry reagents"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Liquid Stable (LS) 2-Part Homocysteine Reagent for quantitative homocysteine measurement in serum and plasma.",
    "Indications for Use Summary": "Intended for the in vitro quantitative determination of total homocysteine in serum and plasma to assist in the diagnosis and treatment of patients suspected of having homocystinuria and hyperhomocysteinemia.",
    "fda_folder": "Clinical Chemistry"
}